DEXTRA: Dialysis Exercise With a Bed Compatible Leg TRAiningstool

Sponsor
University of Erlangen-Nürnberg Medical School (Other)
Overall Status
Completed
CT.gov ID
NCT06045442
Collaborator
(none)
32
1
2
3.2
10

Study Details

Study Description

Brief Summary

This study is a randomised controlled intervention trial for dialysis patients with chronic kidney disease (n=32). The aim of this study is to test the effectiveness of an intradialytic training with a simple bed compatible trainingstool in comparison to a control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intradialytic exercise training
  • Behavioral: Control
N/A

Detailed Description

Patients are randomised to either the intervention or control group at the beginning of the study. Both groups are evaluated at the beginning and after 2 months regarding their body composition, physical performance, fatigue and quality of life. The control group receives usual care. The intervention group receives an intradialytic exercise training with a bed compatible trainingstool.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Random assignment in 1:1 ratio to either the intervention group (intradialytic exercise; twice a week for 30 min per dialysis session) or control group (Usual care)Random assignment in 1:1 ratio to either the intervention group (intradialytic exercise; twice a week for 30 min per dialysis session) or control group (Usual care)
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Exercise During Hemodialysis With a Bed Compatible Trainingstool: a Randomized Controlled Trial
Actual Study Start Date :
May 3, 2023
Actual Primary Completion Date :
Aug 8, 2023
Actual Study Completion Date :
Aug 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

3 months intradialytic exercise intervention: 30 minutes of endurance training at the dialysis unit with a dialysis training device, twice a week.

Behavioral: Intradialytic exercise training
The patients in the intervention group will receive 3 months of endurance training, 2x/week for 30 min. 5 min of this should be a warm-up, 20 min of exertion and 5 min of cool down. The warm-up and cool-down should be equivalent to a very light load (Borg scale 9), whereas the exertion phase should be exhausting for the patients (Borg scale 14-15).

Active Comparator: Control

Usual Care

Behavioral: Control
Usual care

Outcome Measures

Primary Outcome Measures

  1. Sit-to-stand test (STS60) [3 month]

    measured in number of repetitions in 60 seconds

  2. Timed-up-and-go test (TUG) [3 month]

    measured in time (seconds)

Secondary Outcome Measures

  1. muscle mass [3 month]

    measured in kg by bio-impedance analysis

  2. body fat mass [3 month]

    measured in kg by bio-impedance analysis

  3. Quality of life by Kidney Disease Quality of Life Instrument (KDQOL) [3 month]

    measured in change of scale by questionnaire (higher Score = better health; Questions are combined to form items and the average is calculated; Range from 0-100)

  4. Fatigue by Fatigue Assessment Scale (FAS) [3 month]

    measured in change of scale by questionnaire (scores can range from 10 (lowest level of fatigue) to 50 (highest level of fatigue)

  5. activity by Freiburg Questionnaire of physical activity [3 month]

    measured in change of scale by questionnaire (The higher the score, the more active the participant. the lowest level would be a score of 0)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients ≥ 18 years

  • Patients who started dialysis more than 3 months ago

  • Patients must be mentally and physically able to participate in exercise

Exclusion Criteria:
  • Patients who are not mentally or physically able to participate in intradialytic exercise. These include patients with uncontrolled high blood pressure and uncontrolled diabetes mellitus, diseases that impair physical performance or/and could be aggravated by activity, such as ischaemic cardiopathy or symptoms associated with coronary heart disease, chronic coronary heart disease, chronic lung disease and orthopaedic conditions that make exercise impossible.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitätsklinikum Erlangen Erlangen Bavaria Germany 91054

Sponsors and Collaborators

  • University of Erlangen-Nürnberg Medical School

Investigators

  • Study Director: Mario Schiffer, Prof., Universitätsklinikum Erlangen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier:
NCT06045442
Other Study ID Numbers:
  • 23-40-B
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 22, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Erlangen-Nürnberg Medical School
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2023